Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous trading session.
Arvinas (ARVN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This ambitious biotech aims to launch 15 products over the coming five years.